| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | opsonin binding | 8.22e-05 | 25 | 11 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement binding | 1.36e-04 | 32 | 11 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | integrin binding | 3.99e-03 | 175 | 11 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.59e-03 | 188 | 11 | 2 | GO:0005201 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 4.61e-05 | 1483 | 11 | 6 | GO:0048646 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 7.49e-04 | 850 | 11 | 4 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 8.65e-04 | 883 | 11 | 4 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.03e-03 | 91 | 11 | 2 | GO:0033627 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.14e-03 | 410 | 11 | 3 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.16e-03 | 412 | 11 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 1.22e-03 | 420 | 11 | 3 | GO:0045765 | |
| GeneOntologyBiologicalProcess | response to virus | 1.27e-03 | 425 | 11 | 3 | GO:0009615 | |
| GeneOntologyBiologicalProcess | neutrophil chemotaxis | 1.29e-03 | 102 | 11 | 2 | GO:0030593 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.31e-03 | 430 | 11 | 3 | GO:1901342 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.45e-03 | 445 | 11 | 3 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.64e-03 | 115 | 11 | 2 | GO:0090100 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.82e-03 | 482 | 11 | 3 | GO:0007178 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.90e-03 | 124 | 11 | 2 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neutrophil migration | 2.09e-03 | 130 | 11 | 2 | GO:1990266 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.12e-03 | 131 | 11 | 2 | GO:0030510 | |
| GeneOntologyCellularComponent | integrin complex | 1.24e-04 | 32 | 11 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 4.24e-04 | 59 | 11 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | cell surface | 1.94e-03 | 1111 | 11 | 4 | GO:0009986 | |
| MousePheno | decreased lung elastance | 5.99e-05 | 21 | 8 | 2 | MP:0011045 | |
| MousePheno | increased lung compliance | 9.25e-05 | 26 | 8 | 2 | MP:0010895 | |
| MousePheno | abnormal lung elastance | 1.59e-04 | 34 | 8 | 2 | MP:0011043 | |
| MousePheno | abnormal respiration | 2.02e-04 | 598 | 8 | 4 | MP:0001943 | |
| MousePheno | abnormal lung compliance | 2.44e-04 | 42 | 8 | 2 | MP:0002333 | |
| MousePheno | abnormal pulmonary alveolus morphology | 3.14e-04 | 255 | 8 | 3 | MP:0002270 | |
| MousePheno | abnormal pulmonary acinus morphology | 4.31e-04 | 284 | 8 | 3 | MP:0010911 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 4.86e-04 | 296 | 8 | 3 | MP:0010899 | |
| MousePheno | decreased dendritic cell number | 7.18e-04 | 72 | 8 | 2 | MP:0008127 | |
| MousePheno | abnormal respiratory system physiology | 9.57e-04 | 897 | 8 | 4 | MP:0002133 | |
| MousePheno | abnormal response/metabolism to endogenous compounds | 1.49e-03 | 104 | 8 | 2 | MP:0003638 | |
| MousePheno | pathological neovascularization | 1.61e-03 | 108 | 8 | 2 | MP:0003711 | |
| MousePheno | abnormal dendritic cell number | 1.85e-03 | 116 | 8 | 2 | MP:0008125 | |
| MousePheno | alopecia | 1.85e-03 | 116 | 8 | 2 | MP:0000414 | |
| Domain | EGF_extracell | 3.72e-06 | 60 | 10 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.72e-06 | 60 | 10 | 3 | PF07974 | |
| Domain | Integrin_b_cyt | 3.87e-06 | 6 | 10 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 3.87e-06 | 6 | 10 | 2 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 3.87e-06 | 6 | 10 | 2 | IPR014836 | |
| Domain | Integrin_B_tail | 5.41e-06 | 7 | 10 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 5.41e-06 | 7 | 10 | 2 | PF07965 | |
| Domain | Integrin_bsu_tail | 5.41e-06 | 7 | 10 | 2 | IPR012896 | |
| Domain | EGF_1 | 6.68e-06 | 255 | 10 | 4 | PS00022 | |
| Domain | - | 7.02e-06 | 74 | 10 | 3 | 3.40.50.410 | |
| Domain | INB | 7.21e-06 | 8 | 10 | 2 | SM00187 | |
| Domain | Integrin_beta | 7.21e-06 | 8 | 10 | 2 | PF00362 | |
| Domain | Integrin_bsu_VWA | 7.21e-06 | 8 | 10 | 2 | IPR002369 | |
| Domain | EGF-like_CS | 7.33e-06 | 261 | 10 | 4 | IPR013032 | |
| Domain | EGF_2 | 7.78e-06 | 265 | 10 | 4 | PS01186 | |
| Domain | Integin_beta_N | 9.27e-06 | 9 | 10 | 2 | IPR033760 | |
| Domain | Integrin_bsu | 9.27e-06 | 9 | 10 | 2 | IPR015812 | |
| Domain | INTEGRIN_BETA | 9.27e-06 | 9 | 10 | 2 | PS00243 | |
| Domain | PSI_integrin | 9.27e-06 | 9 | 10 | 2 | PF17205 | |
| Domain | VWFA | 9.57e-06 | 82 | 10 | 3 | PS50234 | |
| Domain | VWA | 1.03e-05 | 84 | 10 | 3 | SM00327 | |
| Domain | VWF_A | 1.69e-05 | 99 | 10 | 3 | IPR002035 | |
| Domain | C8 | 2.01e-05 | 13 | 10 | 2 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 2.01e-05 | 13 | 10 | 2 | IPR014853 | |
| Domain | TIL_dom | 2.34e-05 | 14 | 10 | 2 | IPR002919 | |
| Domain | VWFD | 3.08e-05 | 16 | 10 | 2 | PS51233 | |
| Domain | VWD | 3.08e-05 | 16 | 10 | 2 | PF00094 | |
| Domain | VWD | 3.08e-05 | 16 | 10 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.08e-05 | 16 | 10 | 2 | IPR001846 | |
| Domain | Integrin_dom | 7.69e-05 | 25 | 10 | 2 | IPR032695 | |
| Domain | VWC | 9.68e-05 | 28 | 10 | 2 | PF00093 | |
| Domain | VWFC_1 | 1.61e-04 | 36 | 10 | 2 | PS01208 | |
| Domain | VWFC_2 | 1.80e-04 | 38 | 10 | 2 | PS50184 | |
| Domain | VWC | 1.80e-04 | 38 | 10 | 2 | SM00214 | |
| Domain | VWF_dom | 2.20e-04 | 42 | 10 | 2 | IPR001007 | |
| Domain | PSI | 2.41e-04 | 44 | 10 | 2 | IPR016201 | |
| Domain | PSI | 2.64e-04 | 46 | 10 | 2 | SM00423 | |
| Domain | EGF | 6.64e-03 | 235 | 10 | 2 | SM00181 | |
| Domain | EGF_3 | 6.64e-03 | 235 | 10 | 2 | PS50026 | |
| Domain | EGF-like_dom | 7.42e-03 | 249 | 10 | 2 | IPR000742 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.19e-06 | 76 | 7 | 3 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.28e-06 | 85 | 7 | 3 | M16441 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 6.83e-05 | 26 | 7 | 2 | M47 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.01e-04 | 258 | 7 | 3 | MM14572 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.26e-04 | 47 | 7 | 2 | MM14925 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.26e-04 | 47 | 7 | 2 | M39829 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.13e-04 | 300 | 7 | 3 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.92e-04 | 76 | 7 | 2 | M27219 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 9.43e-04 | 96 | 7 | 2 | M39581 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.06e-03 | 102 | 7 | 2 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.06e-03 | 102 | 7 | 2 | MM15830 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.49e-03 | 121 | 7 | 2 | M39823 | |
| Pathway | WP_FOCAL_ADHESION | 3.52e-03 | 187 | 7 | 2 | MM15913 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 4.54e-03 | 213 | 7 | 2 | M18306 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 8.95e-03 | 302 | 7 | 2 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.04e-02 | 326 | 7 | 2 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.12e-02 | 339 | 7 | 2 | M39736 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 24175614 | ||
| Pubmed | 3.05e-06 | 8 | 12 | 2 | 10906324 | ||
| Pubmed | 7.19e-06 | 12 | 12 | 2 | 19693543 | ||
| Pubmed | A novel common variant in DCST2 is associated with length in early life and height in adulthood. | 2.07e-05 | 20 | 12 | 2 | 25281659 | |
| Pubmed | Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. | 3.26e-05 | 25 | 12 | 2 | 17035289 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 3.81e-05 | 27 | 12 | 2 | 31541017 | |
| Pubmed | 8.45e-05 | 40 | 12 | 2 | 28323616 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 1.49e-04 | 53 | 12 | 2 | 1431091 | |
| Interaction | TCF15 interactions | 2.11e-05 | 13 | 11 | 2 | int:TCF15 | |
| Interaction | DUXAP10 interactions | 6.22e-05 | 22 | 11 | 2 | int:DUXAP10 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.56e-03 | 346 | 12 | 2 | chr17p13 | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.20e-06 | 9 | 5 | 2 | 1159 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 5.48e-05 | 24 | 10 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 6.96e-05 | 27 | 10 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_200 | |
| CoexpressionAtlas | lung | 7.11e-05 | 182 | 10 | 3 | lung | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_100 | 1.25e-04 | 36 | 10 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 1.32e-04 | 37 | 10 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.62e-04 | 41 | 10 | 2 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 2.72e-04 | 53 | 10 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 3.37e-04 | 59 | 10 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 3.60e-04 | 61 | 10 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_100 | 4.47e-04 | 68 | 10 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_100 | 5.15e-04 | 73 | 10 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 5.44e-04 | 75 | 10 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 5.58e-04 | 76 | 10 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 5.88e-04 | 78 | 10 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 6.50e-04 | 82 | 10 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 6.82e-04 | 84 | 10 | 2 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100 | 7.14e-04 | 86 | 10 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 7.65e-04 | 89 | 10 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 9.26e-04 | 98 | 10 | 2 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.87e-06 | 158 | 11 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 160 | 11 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 160 | 11 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 181 | 11 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 181 | 11 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 181 | 11 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 183 | 11 | 3 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 189 | 11 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 190 | 11 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.19e-05 | 190 | 11 | 3 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 191 | 11 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 191 | 11 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 192 | 11 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 192 | 11 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 193 | 11 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 193 | 11 | 3 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.25e-05 | 193 | 11 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 193 | 11 | 3 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.25e-05 | 193 | 11 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 194 | 11 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 194 | 11 | 3 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 194 | 11 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 195 | 11 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 11 | 3 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 11 | 3 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 11 | 3 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 195 | 11 | 3 | bad7f2162000f29488b3c4b903dcac9a818621f7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 11 | 3 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 196 | 11 | 3 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 198 | 11 | 3 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-05 | 200 | 11 | 3 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 69 | 11 | 2 | d2ff9cea216122d697822cdd2eecbce8f557728d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 69 | 11 | 2 | 0862e6c8d8af4310b9a1f0879e51ee25115b26b1 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 103 | 11 | 2 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.14e-04 | 125 | 11 | 2 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 127 | 11 | 2 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 4.90e-04 | 136 | 11 | 2 | e272d11bb52f890f6681cc9384aeac27976ec650 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.97e-04 | 137 | 11 | 2 | 12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-04 | 139 | 11 | 2 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 5.19e-04 | 140 | 11 | 2 | cade44740dd3acca7789591aa5a7935d48d5cbee | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.27e-04 | 141 | 11 | 2 | 1e01cfbfbe7d5a6fdaf74c78f286f62ea7898e2d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-04 | 141 | 11 | 2 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | Control-APC-like-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 5.41e-04 | 143 | 11 | 2 | ffc1f497245d559e97e40d1bc4ee14e1ef09040c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.64e-04 | 146 | 11 | 2 | a4f2e3ea79e7154873c01739672ec6454547e6a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.64e-04 | 146 | 11 | 2 | 1e81ad3d6d5d5ad2f0176d2a9593a954d38fa294 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 5.88e-04 | 149 | 11 | 2 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 150 | 11 | 2 | b6e5e04aaf1c5265ac07581868d3159f9292a84c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-04 | 154 | 11 | 2 | ea5d0da5dd8ccfc19969aec35f044db77d589f54 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 6.27e-04 | 154 | 11 | 2 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-04 | 155 | 11 | 2 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.52e-04 | 157 | 11 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-04 | 157 | 11 | 2 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-04 | 157 | 11 | 2 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.52e-04 | 157 | 11 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-04 | 157 | 11 | 2 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 158 | 11 | 2 | 718eafcf8a171bb69b402dc9d69564c3521a62a9 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 158 | 11 | 2 | c8df636412a08c570f235c34d4cff46924a9b11d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-04 | 160 | 11 | 2 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-04 | 160 | 11 | 2 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.94e-04 | 162 | 11 | 2 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 7.11e-04 | 164 | 11 | 2 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 7.11e-04 | 164 | 11 | 2 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 7.19e-04 | 165 | 11 | 2 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 166 | 11 | 2 | d1c61270c7b39bb365020eeafe298a8f88aa887e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-04 | 166 | 11 | 2 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.37e-04 | 167 | 11 | 2 | 0d187e40a5b96b595761f7aea1a0835462d8270f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-04 | 169 | 11 | 2 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.63e-04 | 170 | 11 | 2 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.63e-04 | 170 | 11 | 2 | 67415b098e8ba815b501e557192a9f2b10ee995a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-04 | 170 | 11 | 2 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-04 | 170 | 11 | 2 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.72e-04 | 171 | 11 | 2 | e828b684744a4fdf6b63ec033c4f000b39ca0d51 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-04 | 172 | 11 | 2 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.81e-04 | 172 | 11 | 2 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.81e-04 | 172 | 11 | 2 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.90e-04 | 173 | 11 | 2 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-04 | 173 | 11 | 2 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-04 | 173 | 11 | 2 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-04 | 174 | 11 | 2 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.99e-04 | 174 | 11 | 2 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.99e-04 | 174 | 11 | 2 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.99e-04 | 174 | 11 | 2 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.99e-04 | 174 | 11 | 2 | 758984730cd1c3ccf6866a3a8f03d6e002f3edb6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-04 | 177 | 11 | 2 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-04 | 177 | 11 | 2 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-04 | 179 | 11 | 2 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.46e-04 | 179 | 11 | 2 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-04 | 179 | 11 | 2 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-04 | 180 | 11 | 2 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-04 | 180 | 11 | 2 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.64e-04 | 181 | 11 | 2 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.64e-04 | 181 | 11 | 2 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 181 | 11 | 2 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|World / Lineage, cell class and subclass | 8.64e-04 | 181 | 11 | 2 | 0d096d7d557fd2e71b35e41816e11d7e83cd9210 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.74e-04 | 182 | 11 | 2 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| Computational | Genes in the cancer module 275. | 2.07e-05 | 16 | 5 | 2 | MODULE_275 | |
| Disease | infant body height | 3.18e-05 | 23 | 11 | 2 | EFO_0006785 | |
| Disease | periodontitis | 2.99e-03 | 223 | 11 | 2 | EFO_0000649 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.10e-03 | 227 | 11 | 2 | EFO_0004346, EFO_0010736 | |
| Disease | cancer (implicated_via_orthology) | 4.28e-03 | 268 | 11 | 2 | DOID:162 (implicated_via_orthology) | |
| Disease | longevity | 4.79e-03 | 284 | 11 | 2 | EFO_0004300 | |
| Disease | hypertension | 5.58e-03 | 307 | 11 | 2 | EFO_0000537 | |
| Disease | cortical surface area measurement | 1.18e-02 | 1345 | 11 | 3 | EFO_0010736 | |
| Disease | Liver carcinoma | 1.46e-02 | 507 | 11 | 2 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRGPCACGCGCGSLH | 61 | Q07021 | |
| GCCCCEPGHLPRVLS | 1426 | Q9H6A9 | |
| CGVCACHPGHMGPRC | 476 | P18564 | |
| GPGRGLCFCGKCRCH | 551 | P05107 | |
| EIGPCNKPCVAGCHC | 651 | Q8N8U9 | |
| CCCTFCKCPGIPGPH | 1386 | A8TX70 | |
| LCQCPPGKLGECSGH | 3821 | Q8TDW7 | |
| GGHCPLCVPCKRGCN | 176 | Q8NAJ2 | |
| PVLRPGHCCPTCQGC | 241 | Q6ZWJ8 | |
| PACRHGGVCVRPNKC | 641 | Q96QV1 | |
| SACCCVPPKCGHAGV | 121 | A0A1B0GUW6 | |
| CGHPCIGLCGEPCPK | 1546 | Q9P2E3 |